Researchers examine the prevalence of post-infectious irritable bowel syndrome and post-infectious function dyspepsia following acute gastroenteritis.
By Dr. Liji Thomas, MDReviewed by Benedette Cuffari, M.Sc.Jul 18 2024 In a recent study published in the journal Neurogastroenterology, researchers examine the prevalence of post-infectious irritable bowel syndrome and post-infectious function dyspepsia following acute gastroenteritis.
About the study The current study examines the prevalence of post-infectious IBS and post-infectious FD and stratifies these conditions by the type of organism isolated. Related StoriesWhen categorized by infection type, PI-IBS was five times more likely to develop after acute bacterial gastroenteritis compared to controls and six times more likely to arise after viral or parasitic infections. The repeated association of these disorders with infectious diseases supports the gradual transition to considering DGBI as organic disorders rather than functional disorders.
Following bacterial gastroenteritis, 18% of affected individuals developed PI-IBS, attributed to a five-fold increased risk of PI-IBS after this type of infection. Only 11% of affected individuals developed IBS post-viral gastroenteritis; however, the risk of IBS following this type of infection was six-fold higher than controls and primarily attributed to SARS-CoV-2 infection.
Gastroenteritis Bacteria Brain Campylobacter Coronavirus Diarrhea Gastrointestinal Tract Giardia Gut-Brain Axis Irritable Bowel Syndrome Norovirus Pathogen Pathophysiology Respiratory Rotavirus Salmonella SARS SARS-Cov-2 Severe Acute Respiratory Severe Acute Respiratory Syndrome Syndrome
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Researchers develop new compound designed to treat drug-resistant acute myeloid leukemiaResearchers at Purdue University's College of Science have developed a patent-pending compound called HSN748 to treat drug-resistant acute myeloid leukemia (AML). AML is a cancer that begins in bone marrow and sometimes metastasizes to the central nervous system, liver, lymph nodes, spleen and testicles.
Read more »
Study identifies five sleep types whose changing patterns yield insights into chronic and acute conditionsYour sleep tracker might give you information about more than just your sleep–specifically, it might give you information about chronic conditions such as diabetes and sleep apnea, and illnesses such as COVID-19.
Read more »
Study shows amino acids reduce acute kidney injury after cardiac surgeryAmong adult patients undergoing cardiac surgery, infusion of amino acids reduces the occurrence of acute kidney injury (AKI), according to a study published online June 12 in the New England Journal of Medicine to coincide with the annual Critical Care Reviews Meeting, held from June 12 to 14 in Belfast, Northern Ireland.
Read more »
Study identifies high-risk type of childhood acute leukemia and potential treatment strategyUnderstanding the molecular characteristics of cancer that impact patient outcomes is essential to identifying novel treatment strategies for the most intractable pediatric malignancies. Many of these diseases are difficult to study, however, due to the small number of patients diagnosed each year.
Read more »
Improving treatment for rare acute myeloid leukemia sub-type seen in young adults and childrenPeter Mac clinicians have described how a young patient with a rare, aggressive and only recently described form of acute myeloid leukemia (AML) has responded to genomically-guided targeted therapy.
Read more »
Radiometer celebrates 70 years in acute care diagnosticsIn 1954, Radiometer launched the world’s first commercially available blood gas analyzer. This event catapulted a small Danish company that produced devices for the radio industry into the foray of acute care diagnostics.
Read more »